Literature DB >> 18592406

Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases).

Maria Gerosa1, Cecilia Chighizola, Pier Luigi Meroni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18592406     DOI： 10.1007/s11739-008-0170-y

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  24 in total

Review 1.  Accelerated atherosclerosis in autoimmune rheumatic diseases.

Authors:  Yehuda Shoenfeld; Roberto Gerli; Andrea Doria; Eiji Matsuura; Marco Matucci Cerinic; Nicoletta Ronda; Luis J Jara; Mahmud Abu-Shakra; Pier Luigi Meroni; Yaniv Sherer
Journal:  Circulation       Date:  2005-11-22       Impact factor: 29.690

2.  Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients.

Authors:  N M Shah; M A Khamashta; T Atsumi; G R Hughes
Journal:  Lupus       Date:  1998       Impact factor: 2.911

3.  Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients.

Authors:  M H Rosove; P M Brewer
Journal:  Ann Intern Med       Date:  1992-08-15       Impact factor: 25.391

4.  Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry.

Authors:  G Finazzi; V Brancaccio; M Moia; N Ciaverella; M G Mazzucconi; P C Schinco; M Ruggeri; E M Pogliani; G Gamba; E Rossi; F Baudo; C Manotti; A D'Angelo; G Palareti; V De Stefano; M Berrettini; T Barbui
Journal:  Am J Med       Date:  1996-05       Impact factor: 4.965

Review 5.  Antiphospholipid antibody syndrome and autoimmune diseases.

Authors:  Rochella A Ostrowski; John A Robinson
Journal:  Hematol Oncol Clin North Am       Date:  2008-02       Impact factor: 3.722

6.  Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.

Authors:  José A Girón-González; Enrique García del Río; Carmen Rodríguez; Javier Rodríguez-Martorell; Ascensión Serrano
Journal:  J Rheumatol       Date:  2004-08       Impact factor: 4.666

7.  Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment.

Authors:  R H Derksen; P G de Groot; L Kater; H K Nieuwenhuis
Journal:  Ann Rheum Dis       Date:  1993-09       Impact factor: 19.103

8.  Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study.

Authors:  Monica Galli; Giovanna Borrelli; Eva Marie Jacobsen; Rosa Maria Marfisi; Guido Finazzi; Roberto Marchioli; Finn Wisloff; Stefana Marziali; Olivier Morboeuf; Tiziano Barbui
Journal:  Blood       Date:  2007-04-17       Impact factor: 22.113

9.  A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome.

Authors:  D Erkan; Y Yazici; M G Peterson; L Sammaritano; M D Lockshin
Journal:  Rheumatology (Oxford)       Date:  2002-08       Impact factor: 7.580

10.  Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients.

Authors:  T Hereng; M Lambert; E Hachulla; M Samor; S Dubucquoi; C Caron; D Launay; S Morell-Dubois; V Queyrel; P-Y Hatron
Journal:  Lupus       Date:  2008-01       Impact factor: 2.911
View more
  8 in total

1.  Aspirin thromboprophylaxis of asymptomatic antiphospholipid-positive subjects.

Authors:  Monica Galli
Journal:  Intern Emerg Med       Date:  2008-11-21       Impact factor: 3.397

2.  Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies: only in selected, high risk patients.

Authors:  Mario Bazzan; Antonella Vaccarino
Journal:  Intern Emerg Med       Date:  2008-12-12       Impact factor: 3.397

3.  25 years of the antiphospholipid syndrome: lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipid antibodies.

Authors:  Laura Andreoli; Angela Tincani
Journal:  Intern Emerg Med       Date:  2009-01-08       Impact factor: 3.397

4.  Aspirin in asymptomatic patients with a confirmed positivity of antiphospholipid antibodies.

Authors:  Stefania Basili; Francesco Violi
Journal:  Intern Emerg Med       Date:  2008-09-10       Impact factor: 3.397

Review 5.  Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management-An Insight into Future Approaches.

Authors:  Cecilia Beatrice Chighizola; Tania Ubiali; Pier Luigi Meroni
Journal:  J Immunol Res       Date:  2015-05-05       Impact factor: 4.818

Review 6.  Management of the antiphospholipid syndrome.

Authors:  Gerard Espinosa; Ricard Cervera
Journal:  Auto Immun Highlights       Date:  2010-07-10

Review 7.  Antiphospholipid syndrome.

Authors:  Gerard Espinosa; Ricard Cervera
Journal:  Arthritis Res Ther       Date:  2008-12-15       Impact factor: 5.156

Review 8.  Review on Effectiveness of Primary Prophylaxis in aPLs with and without Risk Factors for Thrombosis: Efficacy and Safety.

Authors:  Nahid A Qushmaq; Samar A Al-Emadi
Journal:  ISRN Rheumatol       Date:  2014-04-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.